Published in Adv Virol on January 13, 2013
Fruit bats as reservoirs of Ebola virus. Nature (2005) 11.05
Isolation and partial characterisation of a new virus causing acute haemorrhagic fever in Zaire. Lancet (1977) 9.23
Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science (2005) 7.07
The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing. Proc Natl Acad Sci U S A (1996) 7.02
Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis (1999) 6.72
Hemorrhagic fever viruses as biological weapons: medical and public health management. JAMA (2002) 6.59
Ebola virus entry requires the cholesterol transporter Niemann-Pick C1. Nature (2011) 5.68
Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor. Nature (2008) 5.24
Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell lines. J Virol (1998) 5.16
TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells. Immunity (2007) 4.49
C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans. J Virol (2002) 4.47
Processing of the Ebola virus glycoprotein by the proprotein convertase furin. Proc Natl Acad Sci U S A (1998) 4.33
Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein. J Virol (2006) 4.24
Marburg virus infection detected in a common African bat. PLoS One (2007) 4.01
Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses. J Exp Med (2002) 3.88
Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations. Arch Virol (2010) 3.77
Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection. Nature (2011) 3.66
Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells. J Clin Invest (2008) 3.59
Preliminary report: isolation of Ebola virus from monkeys imported to USA. Lancet (1990) 3.55
Studies of reservoir hosts for Marburg virus. Emerg Infect Dis (2007) 3.35
Core structure of the envelope glycoprotein GP2 from Ebola virus at 1.9-A resolution. Proc Natl Acad Sci U S A (1999) 3.23
DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cells. Virology (2003) 3.20
Ebola virus glycoproteins induce global surface protein down-modulation and loss of cell adherence. J Virol (2002) 3.06
Biochemical analysis of the secreted and virion glycoproteins of Ebola virus. J Virol (1998) 2.99
Large serological survey showing cocirculation of Ebola and Marburg viruses in Gabonese bat populations, and a high seroprevalence of both viruses in Rousettus aegyptiacus. BMC Infect Dis (2009) 2.82
Ebola virus: from discovery to vaccine. Nat Rev Immunol (2003) 2.72
Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner. PLoS Pathog (2010) 2.60
Cellular entry of ebola virus involves uptake by a macropinocytosis-like mechanism and subsequent trafficking through early and late endosomes. PLoS Pathog (2010) 2.60
Conserved receptor-binding domains of Lake Victoria marburgvirus and Zaire ebolavirus bind a common receptor. J Biol Chem (2006) 2.56
Characterization of filoviruses based on differences in structure and antigenicity of the virion glycoprotein. Virology (1994) 2.48
Molecular biology and evolution of filoviruses. Arch Virol Suppl (1993) 2.45
Folate receptor-alpha is a cofactor for cellular entry by Marburg and Ebola viruses. Cell (2001) 2.39
Human macrophage C-type lectin specific for galactose and N-acetylgalactosamine promotes filovirus entry. J Virol (2004) 2.34
Downregulation of beta1 integrins by Ebola virus glycoprotein: implication for virus entry. Virology (2000) 2.33
Pathogenesis of filoviral haemorrhagic fevers. Lancet Infect Dis (2004) 2.25
Tyro3 family-mediated cell entry of Ebola and Marburg viruses. J Virol (2006) 2.24
Proteolysis of the Ebola virus glycoproteins enhances virus binding and infectivity. J Virol (2007) 2.16
T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria Marburgvirus. Proc Natl Acad Sci U S A (2011) 2.12
Folate receptor alpha and caveolae are not required for Ebola virus glycoprotein-mediated viral infection. J Virol (2003) 2.11
Glycosylation and oligomerization of the spike protein of Marburg virus. Virology (1991) 2.11
Ebola virus entry requires the host-programmed recognition of an intracellular receptor. EMBO J (2012) 2.08
The ecology of Ebola virus. Trends Microbiol (2007) 2.08
Ebola virus: unravelling pathogenesis to combat a deadly disease. Trends Mol Med (2006) 1.92
Filoviridae: a taxonomic home for Marburg and Ebola viruses? Intervirology (1982) 1.89
Marburg virus gene 4 encodes the virion membrane protein, a type I transmembrane glycoprotein. J Virol (1993) 1.85
Marburg and Ebola viruses. Adv Virus Res (1996) 1.81
Distinct mechanisms of entry by envelope glycoproteins of Marburg and Ebola (Zaire) viruses. J Virol (2000) 1.79
Classification, structure, and replication of filoviruses. Curr Top Microbiol Immunol (1999) 1.78
Association of the caveola vesicular system with cellular entry by filoviruses. J Virol (2002) 1.72
Phosphoinositide-3 kinase-Akt pathway controls cellular entry of Ebola virus. PLoS Pathog (2008) 1.66
Human immunodeficiency virus type 1 particles pseudotyped with envelope proteins that fuse at low pH no longer require Nef for optimal infectivity. J Virol (2001) 1.65
Ebolavirus glycoprotein structure and mechanism of entry. Future Virol (2009) 1.56
Analysis of filovirus entry into vero e6 cells, using inhibitors of endocytosis, endosomal acidification, structural integrity, and cathepsin (B and L) activity. J Infect Dis (2007) 1.46
Variation in the glycoprotein and VP35 genes of Marburg virus strains. Virology (1998) 1.45
Proteolytic processing of Marburg virus glycoprotein. Virology (2000) 1.43
The Tyro3 receptor kinase Axl enhances macropinocytosis of Zaire ebolavirus. J Virol (2010) 1.36
Ebola virus enters host cells by macropinocytosis and clathrin-mediated endocytosis. J Infect Dis (2011) 1.33
Mannose-binding lectin binds to Ebola and Marburg envelope glycoproteins, resulting in blocking of virus interaction with DC-SIGN and complement-mediated virus neutralization. J Gen Virol (2005) 1.24
Ebola virus uses clathrin-mediated endocytosis as an entry pathway. Virology (2010) 1.23
Tyrosine kinase receptor Axl enhances entry of Zaire ebolavirus without direct interactions with the viral glycoprotein. Virology (2011) 1.22
The Ebola virus glycoprotein mediates entry via a non-classical dynamin-dependent macropinocytic pathway. Virology (2011) 1.22
Filoviruses require endosomal cysteine proteases for entry but exhibit distinct protease preferences. J Virol (2012) 1.21
Characterization of Marburg virus glycoprotein in viral entry. Virology (2006) 1.21
Rho GTPases modulate entry of Ebola virus and vesicular stomatitis virus pseudotyped vectors. J Virol (2009) 1.20
Filovirus tropism: cellular molecules for viral entry. Front Microbiol (2012) 1.18
Association of ebola virus matrix protein VP40 with microtubules. J Virol (2005) 1.18
Zaire Ebola virus entry into human dendritic cells is insensitive to cathepsin L inhibition. Cell Microbiol (2009) 1.16
Epitopes required for antibody-dependent enhancement of Ebola virus infection. J Infect Dis (2007) 1.16
The signal peptide of the ebolavirus glycoprotein influences interaction with the cellular lectins DC-SIGN and DC-SIGNR. J Virol (2006) 1.09
Seroepidemiological study of filovirus related to Ebola in the Philippines. Lancet (1991) 1.08
Antibody-dependent enhancement of Marburg virus infection. J Infect Dis (2011) 1.02
Different potential of C-type lectin-mediated entry between Marburg virus strains. J Virol (2010) 0.98
Viral haemorrhagic fever and vascular alterations. Hamostaseologie (2008) 0.96
Cediranib: a VEGF receptor tyrosine kinase inhibitor. Future Oncol (2012) 0.93
Identification of novel cellular targets for therapeutic intervention against Ebola virus infection by siRNA screening. Drug Dev Res (2009) 0.91
C-type lectins do not act as functional receptors for filovirus entry into cells. Biochem Biophys Res Commun (2010) 0.90
Differential requirements for clathrin endocytic pathway components in cellular entry by Ebola and Marburg glycoprotein pseudovirions. Virology (2011) 0.89
Phosphatidylserine-mediated phagocytosis of influenza A virus-infected cells by mouse peritoneal macrophages. J Virol (2000) 0.85
Addition of vandetanib to chemotherapy in advanced solid cancers: a meta-analysis. Anticancer Drugs (2012) 0.84
Characterization of the receptor-binding domain of Ebola glycoprotein in viral entry. Virol Sin (2011) 0.84
Comprehensive overview of axitinib development in solid malignancies: focus on metastatic renal cell carcinoma. Clin Adv Hematol Oncol (2012) 0.79
Clinical observation of gefitinib as a first-line therapy in sixty-eight patients with advanced NSCLC. Oncol Lett (2012) 0.77
Visualization of the intracellular behavior of HIV in living cells. J Cell Biol (2002) 6.59
Recruitment of HIV and its receptors to dendritic cell-T cell junctions. Science (2003) 6.22
Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation. Nature (2010) 3.96
Actin is part of pre-initiation complexes and is necessary for transcription by RNA polymerase II. Nat Cell Biol (2004) 3.43
Proteasome inhibitors uncouple rhesus TRIM5alpha restriction of HIV-1 reverse transcription and infection. Proc Natl Acad Sci U S A (2006) 3.43
Evidence for direct involvement of the capsid protein in HIV infection of nondividing cells. PLoS Pathog (2007) 2.75
Human immunodeficiency virus type 1 is trapped by acidic but not by neutralized human cervicovaginal mucus. J Virol (2009) 2.49
Proteasome inhibition reveals that a functional preintegration complex intermediate can be generated during restriction by diverse TRIM5 proteins. J Virol (2006) 2.32
HIV infection of the genital mucosa in women. Curr HIV/AIDS Rep (2009) 2.18
Complementary assays reveal a relationship between HIV-1 uncoating and reverse transcription. Proc Natl Acad Sci U S A (2011) 2.08
Disruption of the actin cytoskeleton can complement the ability of Nef to enhance human immunodeficiency virus type 1 infectivity. J Virol (2004) 2.06
Labeling HIV-1 virions with two fluorescent proteins allows identification of virions that have productively entered the target cell. Virology (2006) 1.97
Visualization of a proteasome-independent intermediate during restriction of HIV-1 by rhesus TRIM5alpha. J Cell Biol (2008) 1.88
Keratinization of the adult male foreskin and implications for male circumcision. AIDS (2010) 1.85
Association of chemokine-mediated block to HIV entry with coreceptor internalization. J Biol Chem (2002) 1.79
Circulating human CD4 and CD8 T cells do not have large intracellular pools of CCR5. Blood (2010) 1.72
Greentree white paper: sexual violence, genitoanal injury, and HIV: priorities for research, policy, and practice. AIDS Res Hum Retroviruses (2012) 1.52
HIV-1 infection of human penile explant tissue and protection by candidate microbicides. AIDS (2009) 1.49
Activated CD34-derived Langerhans cells mediate transinfection with human immunodeficiency virus. J Virol (2007) 1.47
TRIM5 alpha cytoplasmic bodies are highly dynamic structures. Mol Biol Cell (2007) 1.47
Defining the interaction of HIV-1 with the mucosal barriers of the female reproductive tract. J Virol (2013) 1.31
Modulation of Viscoelasticity and HIV Transport as a Function of pH in a Reversibly Crosslinked Hydrogel. Adv Funct Mater (2009) 1.28
Localization of CD4 and CCR5 in living cells. J Virol (2003) 1.28
Ebola virus uses clathrin-mediated endocytosis as an entry pathway. Virology (2010) 1.23
Inhibiting myosin light chain kinase induces apoptosis in vitro and in vivo. Mol Cell Biol (2005) 1.18
Mobility of the human immunodeficiency virus (HIV) receptor CD4 and coreceptor CCR5 in living cells: implications for HIV fusion and entry events. J Virol (2004) 1.17
New paradigms for functional HIV-specific nonneutralizing antibodies. Curr Opin HIV AIDS (2013) 1.09
CRM1-dependent function of a cis-acting RNA export element. Mol Cell Biol (2002) 1.09
Live cell imaging of the HIV-1 life cycle. Trends Microbiol (2008) 1.08
Unclosed HIV-1 capsids suggest a curled sheet model of assembly. J Mol Biol (2012) 1.08
Multiple CCR5 conformations on the cell surface are used differentially by human immunodeficiency viruses resistant or sensitive to CCR5 inhibitors. J Virol (2011) 1.07
APOBEC3G restricts early HIV-1 replication in the cytoplasm of target cells. Virology (2008) 1.04
Physiological levels of virion-associated human immunodeficiency virus type 1 envelope induce coreceptor-dependent calcium flux. J Virol (2006) 1.04
Role of the cytoskeleton in nuclear import. Adv Drug Deliv Rev (2003) 1.03
Mobility of human immunodeficiency virus type 1 Pr55Gag in living cells. J Virol (2006) 1.03
The temperature arrested intermediate of virus-cell fusion is a functional step in HIV infection. Virol J (2006) 1.01
The role of the foreskin in male circumcision: an evidence-based review. Am J Reprod Immunol (2010) 1.01
Differential binding of IgG and IgA to mucus of the female reproductive tract. PLoS One (2013) 1.00
The ins and outs of HIV replication. Cell Microbiol (2005) 1.00
Cellular restriction factors affecting the early stages of HIV replication. Curr HIV/AIDS Rep (2006) 0.98
Capacity for infectious HIV-1 virion capture differs by envelope antibody specificity. J Virol (2014) 0.94
Bridging efficient viral infection. Nat Cell Biol (2007) 0.94
Human cytomegalovirus and human immunodeficiency virus type-1 co-infection in human cervical tissue. Virology (2007) 0.93
Trafficking of some old world primate TRIM5α proteins through the nucleus. Retrovirology (2011) 0.92
Expression of structural proteins in human female and male genital epithelia and implications for sexually transmitted infections. Biol Reprod (2012) 0.91
Differential requirements for clathrin endocytic pathway components in cellular entry by Ebola and Marburg glycoprotein pseudovirions. Virology (2011) 0.89
Characterization of functional domains of equine infectious anemia virus Rev suggests a bipartite RNA-binding domain. J Virol (2006) 0.88
HIV accessory proteins and surviving the host cell. Curr HIV/AIDS Rep (2004) 0.88
Heterotrimeric G-proteins associate with microtubules during differentiation in PC12 pheochromocytoma cells. FASEB J (2003) 0.87
Knockdown of MAP4 and DNAL1 produces a post-fusion and pre-nuclear translocation impairment in HIV-1 replication. Virology (2011) 0.86
The cyclosporin A washout assay to detect HIV-1 uncoating in infected cells. Methods Mol Biol (2014) 0.86
Review of the twelfth West Coast Retrovirus Meeting. Retrovirology (2005) 0.86
No difference in keratin thickness between inner and outer foreskins from elective male circumcisions in Rakai, Uganda. PLoS One (2012) 0.85
Full-length Ebola glycoprotein accumulates in the endoplasmic reticulum. Virol J (2011) 0.85
Recruitment and dynamics of proteasome association with rhTRIM5α cytoplasmic complexes during HIV-1 infection. Traffic (2012) 0.84
Inhibition of the transport of HIV in vitro using a pH-responsive synthetic mucin-like polymer system. Biomaterials (2011) 0.84
Probing the structural states of human immunodeficiency virus type 1 pr55gag by using monoclonal antibodies. J Virol (2007) 0.83
Nanoparticle transport from mouse vagina to adjacent lymph nodes. PLoS One (2012) 0.82
Slower uncoating is associated with impaired replicative capability of simian-tropic HIV-1. PLoS One (2013) 0.81
Enhancement of green fluorescent protein expression in adeno-associated virus with the woodchuck hepatitis virus post-transcriptional regulatory element. Methods Mol Biol (2002) 0.78
Novel three dimensional human endocervix cultures respond to 28-day hormone treatment. Endocrinology (2015) 0.78
Heat shock perturbs TRIM5alpha restriction of human immunodeficiency virus type 1. J Virol (2007) 0.78
Imaging of HIV/host protein interactions. Curr Top Microbiol Immunol (2009) 0.78
Upon thyrotropin binding the thyrotropin receptor is internalized and localized to endosome. Endocrinology (2003) 0.77
Mutational analysis of bovine leukemia virus Rex: identification of a dominant-negative inhibitor. J Virol (2005) 0.77
Short communication: high cellular iron levels are associated with increased HIV infection and replication. AIDS Res Hum Retroviruses (2014) 0.76
Phagocytosis: cell biology view of antiviral function. Curr Opin HIV AIDS (2014) 0.76
Associations of the vaginal microbiota with HIV infection, bacterial vaginosis, and demographic factors. AIDS (2017) 0.75
KAPs off for HIV-1 integration. Cell Host Microbe (2011) 0.75
Using antiubiquitin antibodies to probe the ubiquitination state within rhTRIM5α cytoplasmic bodies. AIDS Res Hum Retroviruses (2013) 0.75
Editorial. AIDS Res Hum Retroviruses (2009) 0.75